IL1RL1 and neoplasm: Indeed, tumor-infiltrating CD8+ T cells showed elevated expression of the IL-33 receptor ST2, while ST2 expression on CD8+ T cells in the TDLN remained low (Fig. 6a and Supplementary Fig. 7a).